Resveratrol, pterostilbene, and dementia

BioFactors

Volumn 44, Issue 1, 2018, Pages 83-90

  Lange, Klaus W ^a   Li, Shiming ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

cognition; dementia; polyphenols; pterostilbene; resveratrol

Indexed keywords

HYDROXYL GROUP; PTEROSTILBENE; RESVERATROL; ANTIOXIDANT; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE;

AGING; ALZHEIMER DISEASE; COGNITION; DEMENTIA; DRUG EFFICACY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPOPHILICITY; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DISEASE MODEL; DRUG EFFECT; MAZE TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CLINICAL TRIALS AS TOPIC; COGNITIVE DYSFUNCTION; DEMENTIA; DISEASE MODELS, ANIMAL; HUMANS; MAZE LEARNING; NEUROPROTECTIVE AGENTS; STILBENES;

EID: 85035144303     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1396     Document Type: Review

References (85)

1. Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., et al. (2016) Alzheimer's disease. Lancet. 388, 505–517.
2. Crews, L., and Masliah, E. (2010) Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum. Mol. Genet. 19, R12–R20.
3. Butterfield, D. A., and Lauderback, C. M. (2002) Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 1050–1060.
4. Gustafson, D. R., Clare Morris, M., Scarmeas, N., Shah, R. C., Sijben, J., et al. (2015) New perspectives on Alzheimer's disease and nutrition. J. Alzheimers Dis. 46, 1111–1127.
5. Huhn, S., Kharabian Masouleh, S., Stumvoll, M., Villringer, A., and Witte, A. V. (2015) Components of a Mediterranean diet and their impact on cognitive functions in aging. Front. Aging Neurosci. 7, 132.
6. Richard, T., Pawlus, A. D., Iglésias, M. L., Pedrot, E., Waffo-Teguo, P., et al. (2011) Neuroprotective properties of resveratrol and derivatives. Ann. N. Y. Acad. Sci. 1215, 103–108.
7. Smid, S. D., Maag, J. L., and Musgrave, I. F. (2012) Dietary polyphenol-derived protection against neurotoxic β-amyloid protein: from molecular to clinical. Food Funct. 3, 1242–1250.
8. Langcake, P., and Pryce, R. J. (1977) A new class of phytoalexins from grapevines. Experientia, 33, 151–152.
9. Burns, J., Yokota, T., Ashihara, H., Lean, M. E., and Crozier, A. (2002) Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 50, 3337–3340.
10. Dal-Pan, A., Pifferi, F., Marchal, J., Picq, J. L., and Aujard, F. (2011) Cognitive performances are selectively enhanced during chronic caloric restriction or resveratrol supplementation in a primate. PLoS One 6, e16581.
11. Willette, A. A., Bendlin, B. B., Colman, R. J., Kastman, E. K., Field, A. S., et al. (2012) Calorie restriction reduces the influence of glucoregulatory dysfunction on regional brain volume in aged rhesus monkeys. Diabetes, 61, 1036–1042.
12. Raskin, J., Cummings, J., Hardy, J., Schuh, K., and Dean, R. A. (2015) Neurobiology of Alzheimer's disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions. Curr. Alzheimer Res. 12, 712–722.
13. Spagnuolo, C., Napolitano, M., Tedesco, I., Moccia, S., Milito, A., et al. (2016) Neuroprotective role of natural polyphenols. Curr. Top. Med. Chem. 16, 1943–1950.
14. Morel, I., Lescoat, G., Cogrel, P., Sergent, O., Pasdeloup, N., et al. (1993) Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on ironloaded rat hepatocyte cultures. Biochem. Pharmacol. 45, 13–19.
15. Subbaramaiah, K., Chung, W. J., Michaluart, F., Telang, N., Tanabe, T., et al. (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273, 21875–21882.
16. Surh, Y. (1999) Moleular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428, 305–327.
17. Baur, J. A., and Sinclair, D. A. (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493–506.
18. Venigalla, M., Sonego, S., Gyengesi, E., Sharman, M. J., and Münch, G. (2016) Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. Neurochem. Int. 95, 63–74.
19. Albani, D., Polito, L., Signorini, A., and Forloni, G. (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36, 370–376.
20. Das, S., and Das, D. K. (2007) Anti-inflammatory responses of resveratrol. Inflamm. Allergy Drug Targets 6, 168–173.
21. Liu, D., Xie, K., Yang, X., Gu, J., Ge, L., et al. (2014) Resveratrol reverses the effects of chronic unpredictable mild stress on behavior, serum corticosterone levels and BDNF expression in rats. Behav. Brain Res. 264, 9–16.
22. Rege, S. D., Geetha, T., Broderick, T. L., and Babu, J. R. (2015) Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells. Curr. Alzheimer Res. 12, 147–156.
23. Bastianetto, S., Zheng, W. H., and Quirion, R. (2000) Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br. J. Pharmacol. 131, 711–720.
24. Nicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A. E., and Tredici, G. (2001) Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line. Neurosci. Lett. 302, 41–44.
25. Virgili, M., and Contestabile, A. (2000) Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci. Lett. 281, 123–126.
26. Moussa, C., Hebron, M., Huang, X., Ahn, J., Rissman, R. A., et al. (2017) Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J. Neuroinflammation 14:1.
27. Ahmed, T., Javed, S., Javed, S., Tariq, A., Šamec, D., et al. (2017) Resveratrol and Alzheimer's disease: mechanistic insights. Mol. Neurobiol. 54, 2622–2635.
28. Savaskan, E., Olivieri, G., Meier, F., Seifritz, E., Wirz-Justice, A., et al. (2003) Red wine ingredient resveratrol protects from β-amyloid neurotoxicity. Gerontology 49, 380–383.
29. Jang, J. H., and Surh, Y. J. (2003) Protective effects of resveratrol on β-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 34, 1100–1110.
30. Han, Y. S., Zheng, W. H., Bastianetto, S., Chabot, J. G., and Quirion, R. (2004) Neuroprotective effects of resveratrol against β-amyloid induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br. J. Pharmacol. 141, 997–1005.
31. Kim, Y. A., Lim, S. Y., Rhee, S. H., Park, K. Y., Kim, C. H., et al. (2006) Resveratrol inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression in β-amyloid-treated C6 glioma cells. Int. J. Mol. Med. 17, 1069–1075.
32. Marambaud, P., Zhao, H., and Davies, P. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides. J. Biol. Chem. 280, 37377–37382.
33. Patel, M. I., Gupta, A., and Dey, C. S. (2011) Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK. Pharmacol. Rep. 63, 1162–1168.
34. Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., et al. (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloidpeptide metabolism. J. Biol. Chem. 285, 9100–9113.
35. Yao, Y., Li, J., Niu, Y., Yu, J. Q., Yan, L., et al. (2015) Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase. Mol. Med. Rep. 12, 6133–6139.
36. Regitz, C., Fitzenberger, E., Mahn, F. L., Dußling, L. M., and Wenzel, U. (2016) Resveratrol reduces amyloid-β (Aβ1–42)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans. Eur. J. Nutr. 55, 741–747.
37. Blokland, A. (2005) Scopolamine-induced deficits in cognitive performance: a review of animal studies. Scopolamine Rev. 1, 1–76.
38. Kwon, S. H., Kim, H. C., Lee, S. Y., and Jang, C. G. (2009) Loganin improves learning memory impairments induced by scopolamine in mice. Eur. J. Pharmacol. 619, 44–49.
39. Gupta, R., Gupta, L. K., Mediratta, P. K., and Bhattacharya, S. K. (2012) Effect of resveratrol on scopolamine-induced cognitive impairment in mice. Pharmacol. Rep. 64, 438–444.
40. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–342.
41. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109–11022.
42. Chung, S., Yao, H., Caito, S., Hwang, J. W., Arunachalam, G., et al. (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 501, 79–90.
43. Porquet, D., Casadesús, G., Bayod, S., Vicente, A., Canudas, A. M., et al. (2013) Dietary resveratrol prevents Alzheimer's markers and increases life span in SAMP8. Age 35, 1851–1865.
44. Porquet, D., Griñán-Ferré, C., Ferrer, I., Camins, A., Sanfelio, C., et al. (2014) Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease. J. Alzheimer Dis. 42, 1209–1220.
45. Wang, G., Chen, L., Pan, X., Chen, J., Wang, L., et al. (2016) The effect of resveratrol on β amyloid-induced memory impairment involves inhibition of phosphodiesterase-4 related signaling. Oncotarget 7, 17380–17392.
46. Huang, T. C., Lu, K. T., Wo, Y. Y., and Yang, Y. L. (2011) Resveratrol protects rats from Aβ-induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS One 6, e29102.
47. Marr, R. A., Rockenstein, E., Mukherjee, A., Kindy, M. S., Hersh, L. B., et al. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23, 1992–1996.
48. El-Sayed, N. S., and Bayan, Y. (2015) Possible role of resveratrol targeting estradiol and neprilysin pathways in lipopolysaccharide model of Alzheimer disease. Adv. Exp. Med. Biol. 822, 107–118.
49. Zhao, H., Niu, Q., Li, X., Liu, T., Xu, Y., et al. (2012) Long-term resveratrol consumption protects ovariectomized rats chronically treated with D-galactose from developing memory decline without effects on the uterus. Brain Res. 1467, 67–80.
50. Zhao, H. F., Li, N., Wang, Q., Cheng, X. J., Li, X. M., et al. (2015) Resveratrol decreases the insoluble Aβ1–42 level in hippocampus and protects the integrity of the blood-brain barrier in AD rats. Neuroscience 310, 641–649.
51. Jellinger, K. A. (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol. 113, 349–388.
52. Cechetti, F., Pagnussat, A. S., Worm, P. V., Elsner, V. R., Ben, J., et al. (2012) Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res. Bull. 87, 109–116.
53. Xi, Y., Wang, M., Zhang, W., Bai, M., Du, Y., et al. (2014) Neuronal damage, central cholinergic dysfunction and oxidative damage correlate with cognitive deficits in rats with chronic cerebral hypoperfusion. Neurobiol. Learn. Mem. 109, 7–19.
54. Anastácio, J. R., Netto, C. A., Castro, C. C., Sanches, E. F., Ferreira, D. C., et al. (2014) Resveratrol treatment has neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion. Neurol. Res. 36, 627–633.
55. Ma, X., Sun, Z., Liu, Y., Jia, Y., Zhang, B., et al. (2013) Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural. Regen. Res. 8, 2050–2059.
56. Shen, D., Tian, X., Sang, W., and Song, R. (2016) Effect of melatonin and resveratrol against memory Impairment and hippocampal damage in a rat model of vascular dementia. Neuroimmunomodulation, 23, 318–331.
57. Sun, Z. K., Ma, X. R., Jia, Y. J., Liu, Y. R., Zhang, J. W., et al. (2014) Effects of resveratrol on apoptosis in a rat model of vascular dementia. Exp. Ther. Med. 7, 843–848.
58. Li, H., Wang, J., Wang, P., Rao, Y., and Chen, L. (2016) Resveratrol reverses the synaptic plasticity deficits in a chronic cerebral hypoperfusion rat model. J. Stroke Crerebrovasc. Dis. 25, 122–128.
59. Ozacmak, V. H., Sayan-Ozacmak, H., and Barut, F. (2016) Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to chronic cerebral hypoperfusion. Nutr. Neurosci. 19, 176–186.
60. Estrela, J. M., Ortega, A., Mena, S., Rodriguez, M. L., and Asensi, M. (2013) Pterostilbene: biomedical applications. Crit. Rev. Clin. Lab. Sci. 50, 65–78.
61. Joseph, J. A., Fisher, D. R., Cheng, V., Rimando, A. M., and Shukitt-Hale, B. (2008) Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. J. Agric. Food Chem. 56, 10544–10551.
62. Li, Y., Qiang, X., Li, Y., Yang, X., Luo, L., et al. (2016) Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease. Bioorg. Med. Chem. Lett. 26, 2035–2039.
63. Naik, B., Nirwane, A., and Majumdar, A. (2017) Pterostilbene ameliorates intracerebroventricular streptozotocin induced memory decline in rats. Cogn. Neurodyn. 11, 35–49.
64. Hou, Y., Xie, G., Miao, F., Ding, L., Mou, Y., et al. (2014) Pterostilbene attenuates lipopolysaccharide-induced learning and memory impairment possibly via inhibiting microglia activation and protecting neuronal injury in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 54, 92–102.
65. Chang, J., Rimando, A., Pallas, M., Camins, A., Porquet, D., et al. (2012) Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiol. Aging, 33, 2062–2071.
66. Brasnyo, P., Molnar, G. A., Mohas, M., Marko, L., Laczy, B., et al. (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br. J. Nutr. 106, 383–389.
67. Bhatt, J. K., Thomas, S., and Nanjan, M. J. (2012) Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr. Res. 32, 537–541.
68. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., et al. (2012) Pilot study of resveratrol in older adults with impaired glucose tolerance. J. Gerontol. A Biol. Sci. Med. Sci. 67, 1307–1312.
69. Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., et al. (2010) Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 91, 1590–1597.
70. Witte, A. V., Kerti, L., Margulies, D. S., and Floel, A. (2014) Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J. Neurosci. 34, 7862–7870.
71. Turner, R. S., Thomas, R. G., Craft, S., van Dyck, C. H., Mintzer, J., et al. (2015) A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 85, 1383–1391.
72. Wightman, E. L., Haskell-Ramsay, C. F., Reay, J. L., Williamson, G., Dew, T., et al. (2015) The effects of chronic trans-resveratrol supplementation on aspects of cognitive function, mood, sleep, health and cerebral blood flow in healthy, young humans. Br. J. Nutr. 114, 1427–1437.
73. Wong, R. H., Berry, N. M., Coates, A. M., Buckley, J. D., Bryan, J., et al. (2013) Chronic resveratrol consumption improves brachial flow mediated dilatation in healthy obese adults. J. Hypertens. 31, 1819–1827.
74. Lee, J., Torosyan, N., and Silverman, D. H. (2017) Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study. Exp. Gerontol. 87, 121–128.
75. Genazzani, A. R., Bernardi, F., Pluchino, N., Begliuomini, S., Lenzi, E., et al. (2005) Endocrinology of menopausal transition and its brain implications. CNS Spectr. 10, 449–457.
76. Evans, H. M., Howe, P. R. C., and Wong, R. H. X. (2017) Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; A 14-week randomized placebo-controlled intervention trial. Nutrients 9, 27.
77. Köbe, T., Witte, A. V., Schnelle, A., Tesky, V. A., Pantel, J., et al. (2017) Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment. Front. Neurosci. 11, 105.
78. Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., et al. (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 6, e19881.
79. Yiu, E. M., Tai, G., Peverill, R. E., Lee, K. J., Croft, K. D., et al. (2015) An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels. J. Neurol. 262, 1344–1353.
80. Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N., and McCormick, D. L. (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother. Pharmacol. 68, 593e601.
81. Ma, T., Tan, M. S., Yu, J. T., and Tan, L. (2014) Resveratrol as a therapeutic agent for Alzheimer's disease. Biomed. Res. Int. 2014, 350516.
82. Pasinetti, G. M., Wang, J., Ho, L., Zhao, W., and Dubner, L. (2015) Roles of resveratrol and other grape-derived polyphenols in Alzheimer's disease prevention and treatment. Biochim. Biophys. Acta 1852, 1202–1208.
83. Lu, C., Guo, Y., Li, J., Yao, M., Liao, Q., et al. (2012) Design, synthesis, and evaluation of resveratrol derivatives as Ass((1)-(4)(2)) aggregation inhibitors, antioxidants, and neuroprotective agents. Bioorg. Med. Chem. Lett. 22, 7683–7687.
84. Cherniack, E. P. (2012) A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders. Br. J. Nutr. 108, 794–800.
85. Lange, K. W. (2018) Red wine, resveratrol and Alzheimer's disease. Mov. Nutr. Health Dis. 2, 31.